SE430503B - Substituerade 2-fenylaminoimidazolin-(2)-er med speciella teraputiska egenskaper, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem - Google Patents

Substituerade 2-fenylaminoimidazolin-(2)-er med speciella teraputiska egenskaper, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem

Info

Publication number
SE430503B
SE430503B SE7910157A SE7910157A SE430503B SE 430503 B SE430503 B SE 430503B SE 7910157 A SE7910157 A SE 7910157A SE 7910157 A SE7910157 A SE 7910157A SE 430503 B SE430503 B SE 430503B
Authority
SE
Sweden
Prior art keywords
pharmaceutically acceptable
imidazoline
acceptable salts
amino
compounds
Prior art date
Application number
SE7910157A
Other languages
English (en)
Swedish (sv)
Other versions
SE7910157L (sv
Inventor
E Manghisi
G Cascio
G B Fregnan
G Ferni
Original Assignee
Luso Farmaco Inst
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from IT30738/78A external-priority patent/IT1101727B/it
Priority claimed from IT27202/79A external-priority patent/IT1127215B/it
Application filed by Luso Farmaco Inst filed Critical Luso Farmaco Inst
Publication of SE7910157L publication Critical patent/SE7910157L/xx
Publication of SE430503B publication Critical patent/SE430503B/sv

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/335—Heterocyclic compounds having oxygen as the only ring hetero atom, e.g. fungichromin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D233/00—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings
    • C07D233/04—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member
    • C07D233/28—Heterocyclic compounds containing 1,3-diazole or hydrogenated 1,3-diazole rings, not condensed with other rings having one double bond between ring members or between a ring member and a non-ring member with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D233/44—Nitrogen atoms not forming part of a nitro radical
    • C07D233/50—Nitrogen atoms not forming part of a nitro radical with carbocyclic radicals directly attached to said nitrogen atoms
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D307/00—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom
    • C07D307/02—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings
    • C07D307/04—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D307/18—Heterocyclic compounds containing five-membered rings having one oxygen atom as the only ring hetero atom not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D307/22—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D309/00—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings
    • C07D309/02—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members
    • C07D309/08—Heterocyclic compounds containing six-membered rings having one oxygen atom as the only ring hetero atom, not condensed with other rings having no double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
    • C07D309/14—Nitrogen atoms not forming part of a nitro radical
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07D—HETEROCYCLIC COMPOUNDS
    • C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
    • C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
    • C07D405/12—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a chain containing hetero atoms as chain links

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Epidemiology (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • General Health & Medical Sciences (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)
SE7910157A 1978-12-12 1979-12-10 Substituerade 2-fenylaminoimidazolin-(2)-er med speciella teraputiska egenskaper, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem SE430503B (sv)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
IT30738/78A IT1101727B (it) 1978-12-12 1978-12-12 Nuove 2-fenilammino-imidazoline-(2) sostituite, dotate di particolari proprieta' terapeutiche, loro processo di sintesi e composizioni farmaceutiche
IT27202/79A IT1127215B (it) 1979-11-12 1979-11-12 Nuove 2-fenilammino-imidazoline-(2)sostitutite,dotate di particolari proprieta' terapeutiche,loro processo di sintesi e composizioni farmaceutiche

Publications (2)

Publication Number Publication Date
SE7910157L SE7910157L (sv) 1980-06-13
SE430503B true SE430503B (sv) 1983-11-21

Family

ID=26328719

Family Applications (1)

Application Number Title Priority Date Filing Date
SE7910157A SE430503B (sv) 1978-12-12 1979-12-10 Substituerade 2-fenylaminoimidazolin-(2)-er med speciella teraputiska egenskaper, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem

Country Status (13)

Country Link
US (1) US4262006A (fr)
CA (1) CA1137090A (fr)
CH (1) CH645358A5 (fr)
DE (1) DE2949971C2 (fr)
DK (1) DK159317C (fr)
ES (1) ES8102565A1 (fr)
FI (1) FI65428C (fr)
FR (1) FR2444036A1 (fr)
GB (1) GB2041355B (fr)
NL (1) NL183139C (fr)
NO (1) NO152171C (fr)
PT (1) PT70584A (fr)
SE (1) SE430503B (fr)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US4398028A (en) * 1977-01-14 1983-08-09 Sandoz Ltd. Bicyclic heterocyclic amino derivatives
KR101881115B1 (ko) * 2015-06-25 2018-08-20 가천대학교 산학협력단 신규 2-치환된 테트라하이드로피란 또는 2-치환된 테트라하이드로퓨란 유도체 화합물, 이의 제조방법 및 이의 용도

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DD95843A5 (fr) * 1971-01-21 1973-02-20
US3850926A (en) * 1971-01-21 1974-11-26 Boehringer Sohn Ingelheim 2-(n-substituted-phenylamino)-imidazolines-(2)

Also Published As

Publication number Publication date
ES487167A0 (es) 1980-12-16
GB2041355B (en) 1983-02-16
DK159317C (da) 1991-02-25
SE7910157L (sv) 1980-06-13
NO794047L (no) 1980-06-13
NL7908853A (nl) 1980-06-16
NL183139B (nl) 1988-03-01
DE2949971A1 (de) 1980-07-03
DE2949971C2 (de) 1983-11-24
FR2444036A1 (fr) 1980-07-11
FI65428C (fi) 1984-05-10
ES8102565A1 (es) 1980-12-16
CA1137090A (fr) 1982-12-07
FI793727A (fi) 1980-06-13
US4262006A (en) 1981-04-14
CH645358A5 (it) 1984-09-28
FI65428B (fi) 1984-01-31
PT70584A (en) 1980-01-01
DK512479A (da) 1980-06-13
NO152171B (no) 1985-05-06
DK159317B (da) 1990-10-01
NO152171C (no) 1985-08-14
FR2444036B1 (fr) 1985-03-15
NL183139C (nl) 1988-08-01
GB2041355A (en) 1980-09-10

Similar Documents

Publication Publication Date Title
DE2951675C2 (de) Guanidinothiazolverbindungen, Verfahren zu deren Herstellung und Arzneimittelzubereitungen
SE457081B (sv) 1,2-diaminocyklobutan-3,4-dioner, foerfarande foer framstaellning av dessa, mellanprodukt och en farmaceutisk komposition
DE3935514A1 (de) Neue bicyclo-imidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
DE4129603A1 (de) Kondensierte 5-gliedrige heterocyclen, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
EP0209707A2 (fr) Aryl-2-imidazoles, compositions pharmaceutiques contenant ces composés et procédé pour leur préparation
AU598560B2 (en) 1H, 3H-pyrrolo(1,2-c)thiazole derivatives, preparation thereof and pharmaceutical compositions containing them
KR970011396B1 (ko) 티아졸로 [5, 4-b] 아제핀 화합물
EP0133530B1 (fr) Dérivés de 1,6-naphthyridinone, procédé pour leur préparation et médicaments les contenant
DD263772A5 (de) Verfahren zur herstellung neuer 1h, 3h-pyrrolo[1,2-c]thiazolderivate
EP0053767B1 (fr) Dérivés tricycliques de la cytosine pour utilisation en médicaments et procédé pour leur préparation
EP0008652B1 (fr) Nouveaux produits intermédiaires et leur utilisation pour la préparation de nouveaux dérivés d'oxadiazolo-pyrimidine
EP1874733B1 (fr) Derives d'uree cycliques substitues et leur utilisation comme modulateurs du recepteur vanilloide 1
EP0180834B1 (fr) Dérivés de la 4-oxopyrido[2,3-d]pyrimidine, procédé pour leur préparation et médicaments les contenant
EP0304534A1 (fr) Dérivés de la dihydropyridazinone, procédé pour leur préparation et médicaments contenant ces composés
EP0173933B1 (fr) Dérivés de la 1,6-naphthyridine, procédé pour leur préparation et médicaments les contenant
SE430503B (sv) Substituerade 2-fenylaminoimidazolin-(2)-er med speciella teraputiska egenskaper, forfarande for deras framstellning och farmaceutiska kompositioner innehallande dem
EP0665228A1 (fr) Compositions pharmaceutiques contenant 3-phenylsulfonyl-3,7-diazabicyclo 3,3,1 nonanes
US4526973A (en) Chemical compounds
DK170047B1 (da) Med basiske heterocycliske grupper substituerede 5-halogen-thienoisothiazol-3(2H)-on-1,1-dioxider og salte deraf, fremgangsmåde til fremstilling af sådanne forbindelser, farmaceutiske præparater indeholdende disse forbindelser og forbindelsernes anvendelse ved fremstilling af lægemidler til behandling af angsttilstande
DE3734083A1 (de) Benzimidazole, verfahren zu ihrer herstellung und diese verbindungen enthaltende arzneimittel
US4503051A (en) Substituted 3-cyclobutene-1,2-diones, pharmaceutical compositions thereof and methods of use
EP0360784B1 (fr) Dérivés de thiényloxy-alcoylamine, procédé de préparation et médicaments contenant ces composés
US4539316A (en) Pyridine derivatives of 1,2-diaminocyclobutene-3,4-diones
EP0037471B1 (fr) 1-Aroyl-2-phénylamino-2-imidazolines, leur préparation et leurs compositions pharmaceutiques
EP0007643B1 (fr) Dérivés de l'oxadiazolotriazine

Legal Events

Date Code Title Description
NUG Patent has lapsed

Ref document number: 7910157-2

Effective date: 19920704

Format of ref document f/p: F